Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis have?
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis has 1,075 citations in the OpenAlex counts ScholarIQ stores.
When was Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis published?
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis has 2017 year in the ScholarIQ index.
What is the open-access status of Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis?
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis has bronze oa status in the ScholarIQ index.
What is the DOI of Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis?
The DOI for Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis is on the source record.
What is the PMID of Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis?
The PMID for Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis is on the source record.
What is the OpenAlex record for Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis?
The OpenAlex for Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis is on the source record.